Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.

Carcinogenesis - 1 Jun 2010

Dong Jing, Dai Juncheng, Shu Yongqian, Pan Shiyang, Xu Lin, Chen Wenping, Wang Yi, Jin Guangfu, Ma Hongxia, Zhang Mingfeng, Hu Zhibin, Shen Hongbing

Abstract excerpt

Over the last decades, combined chemotherapies that inhibit different signalling pathways together have been demonstrated to be more effective to treat the non-small-cell lung cancer (NSCLC). The epidermal growth factor receptor (EGFR) and the vascular endothelium growth factor (VEGF) are two key targets. Polymorphisms in EGFR and VEGF genes have been identified to be associated with therapy-response and cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to China

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Prognosis

Share to Survival Rate

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 20400478
DOI: 10.1093/carcin/bgq079

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.PMID 20400478Read ↗

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancer.Semantic proximity Read ↗

VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.Semantic proximity Read ↗

Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population.Semantic proximity Read ↗

Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.Semantic proximity Read ↗

Prognostic implications of the EGFR polymorphism rs763317 and clinical variables among young Chinese lung cancer population.Semantic proximity Read ↗

Molecular profiling and prognostic biomarkers in chinese non-small cell lung cancer cohort.Semantic proximity Read ↗

The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.Semantic proximity Read ↗

Survival prediction model for non-small cell lung cancer based on somatic mutations.Semantic proximity Read ↗

Role of VEGF gene polymorphisms in the clinical outcome of non-small cell lung cancer.Semantic proximity Read ↗

Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of NOTCH signaling pathway-related genes and the prognosis of NSCLCSemantic proximity Read ↗

MDM2 SNP309 contributes to non-small cell lung cancer survival in Chinese.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.